Short Read Sequencing Market Synopsis

Short-read Sequencing Market Size Was Valued at USD 6.32 Billion in 2023, and is Projected to Reach USD 24.7 Billion by 2032, Growing at a CAGR of 18.6% From 2024-2032.

Short read sequencing is a relatively new platform that is overtly known as next generation sequencing or NGS; it is a process used to determine and identify the number and sequence of nucleotide in the DNA. This process yields million of short fragments of DNA which are usually below 300 base pairs in length and are generated in one run. These sequences are than compared with a reference genome to resolve the original DNA sequence of the marker gene. Short read sequencing is used in nearly all types of analysis, from whole-genome sequencing, and transcriptome profiling through all that involves mutations because it yields vast data, is reliable, and is not very expensive as other approaches.

• Market of short read sequencing has however been on an upward trend recently and this is due to advancement in genomics and utilization of high throughput machines. The nature of second generation sequencing is reading the genomes in shorter stretches at a time and the sequence output can as small as fifty to three hundred base pairs. This is precisely the case of this particular technology as it has really changed the genomics in terms of sequencing because this is an ultra fast, ultra accurate, relatively cheap technology and its applicability is under a number of ways including diagnostics, pharmacogenomics applications of genomics, agricultural and ecological applications of genomics. 
• Implementation of short read sequencing in frame of clinical diagnostics can be considered as one of the major growth drivers in the market for short read sequencing. That is why the use of next generation sequencing or NGS has enabled identification of mutations and other variations of genes implicated in many diseases for example, cancer, genetic disorder, and infectious diseases. For example in Oncology, short read sequencing helps in establishing somatic mutations, copy number variations and gene fusions that guide the treatment and therapies that will be administered to the patient. In addition, NIPT and carrier screening where genetic data is acquired with minimal intrusiveness to the concerned patient also require further. 
• The fourth favorable indicator that influences the market’s development is the proambitious technological development and capital costs for sequencing. Major players like Illumina, Thermo Fischer Scientific and BGI Group are prominent involved in development of the latest sequencing technologies and reagents therefore improving the quality yield and cost of short read sequencing. A refinement of the high-throughput sequencers such as Illumina’s NovaSeq series allowed many forms of NGS, in which they sequence genons, transcriptons and epigeons in mass. 
• In addition, one can confidently state that, the short read sequencing market has been constantly developing especially in agriculture and ecology field. In agriculture, NGS is used in plants and animals to identify genes which are associated with the desirable phenotype such as disease resistance and enhanced yield. Short read sequencing is used by environmental scientists in everything from studying Biodiversity, Microbiome, and any other aspect of ecosystem function in response to variation in environment. Such diversification in usage from simple and specific human health issues has led to formation of other market opportunities.
• However, the short read sequencing market still has some challenges which are Data Handling and Data Analysis. Thus, personal gene expression leads to huge date acquisition after NGS and analysis of these dates requires scientific bioinformatics and appropriate computational facilities. Additionally, the analysis of genomic data consumes a lot of time than the traditional typology data hence the need to employ experts to check and ensure accuracy. Addressing these issues with new bioinformatics products and education paradigms will be central to the further advancement of the market.
• As a result, It is reasonable to conclude that the market of short read sequencing will maintain high velocity of growth due to its impact on the advancement of Genome and Clinic Diagnostics. It can therefore be noted that NGS has high likelihood since sequencing technologies is a continually evolving field supported by numerous applications of the technologies in different fields. Nevertheless, the challenges linked with data processing and analysis will become critical to open up new possibilities of short read sequencing and create values for diverse sectors.

Short Read Sequencing Market Trend Analysis

Increasing Adoption of Next-Generation Sequencing (NGS) Technologies

• Recent development in genomics has been defined by increase and development of NGS technologies, and specifically short read sequencing that introduce different characteristics concerning the speed, the cost, and the accuracy of DNA sequencing. Illumina and Thermo Fisher Scientific currently have short read sequencing technology that is highly through put and very accurate for research to diagnostics. It is due to various factors like the cost of sequencing is declining over and over again now, the efficiency of tools & techniques in bioinformatics, least important the growing importance of personalized medicine, & genomics.
• The usage of short read sequencing can be illustrated in almost every field, starting with oncology which means cancer genomics and associated targeted therapy as well as exotic monogenic diseases that imply pathogenic mutations. Also, NGS is supported by other technologies, such as CRISPR for genome editing and synthetic biology, which is at the root of the newly emerging biology, thereby stimulating its application further. Therefore the market for short read sequencing is quickly expanding; there is also increasing amounts of research and development being channeled to the particular field in addition to there being additional clinical and research laboratories actively integrating these technologies.

Advancements in Sequencing Technology

• The current competence in sequencing technology and particularly in the short read sequencing market is enabling very rapid growth in genomic research, as well as trends in Personalized Medicine. One of the most popular advanced techniques is next-generation sequencing or short read sequencing which has evolved from increased resolution, shorter turn-around time and less costs than what used to be done. Current major players in this market segment include Illumina, Thermo Fisher Scientific, and BGI using WGS, which is constantly expanding the new platform, as well as enhancing the results of the obtained data throughput. Presently, ai and machine learning have improved the handling and understanding of high compliant big data for genomics with improved biomarkers and targets in mind.
• In addition, enhancements such as easy and better sequencing chemistry together with miniaturization of the sequencing platform has allowed for the execution of larger scale genomic research as well as clinic diagnostics. Of the mentioned applications of NGS, use in oncology and rare as well as infectious diseases diagnosis have increased because of the fast identification of variations and mutations. Also, the establishment of new forms of library preparation and sequencing beads has facilitated the application of NGS in even more laboratories at Centre, researchers and clinicians. None of these appears to be a single way of improving the simple knowledge of the human genome on the other hand it is assisting a lot in the practice of the precision medicines where every patient he or she receives treatment according to the genetic make up. Thus, based on the further progression of the technology and expansion of the fields where short read sequencing is being applied, this is stated that the market for the technology should remain stable and progressive.

Short Read Sequencing Market Segment Analysis:

Short Read Sequencing Market is Segmented based on  Product, Workflow, Application and End Use.

By Product , Instruments segment is expected to dominate the market during the forecast period

• Similar to the separator market, the market segmentation by the product demonstrates the difference in the market dynamics and instruments’ development in the field of services and reagents and consumables sectors. Sequencers and related equipment accounts for a large portion of instruments because sequencers are relatively costly and these exciting accidental features make people need sequencers with higher performance. Reagents, enzymes and sequencing kits are repetitive components and are directly related to the market because their sale is regular since they are needed in each sequencing process. It increases from brand creation and given that the product undergoes replacement then a constant market is assured www. competitruck. com.
• Routine services, ordering of service, data analysis, and other simple services that institutions may not, or prefer not to, create in-house are provided. This is evident in that while the services segment is on the rise, research and clinical laboratories are finding it difficult to get outsourced solutions, let alone specific special and cost effective ways of managing the ever incresingly voluminous and complex nature of sequencing data. To sum up, everything in the Short Read Sequencing market including demand is attributed to the development of instruments, unrelenting demand for consumables and increased usage of the service that not only meets the research and clinical application requirements.

By Application , Whole Genome Sequencing segment held the largest share in 2023

• The market for Applications of Short Read Sequencing is categorized into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing and Other services. Whole Genome Sequencing is a process that involves analyzing the whole genome of an organism to detect all relative variations of genome structure. Whole Exome Sequencing arises when dealing with only the exomes of the genes, and this makes it a good tool when linking up various diseases with regard to mutations since WES is cheaper, and does not require much data when compared to WGS.
• On the other hand, Targeted Sequencing & Resequencing requires attention to be directed on the areas of the genome that is, it can only analyze certain genetic changes or the areas known to cause diseases. It is used in clinical research work and diagnostics because it’s accurate and fast in relation to the presentation of data. Of course it is worthwhile to state that the “Others” category can encompass other application and trends which are somehow associated with short read sequencing but do not belong to the mentioned types that contribute to the market growth. All these applications have equal importance while improving the genomics research and building the area of personalized medicine and therefore fueling the need for evolution of short read sequencing.

Short Read Sequencing Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

• The Asia Pacific region is believed to capture the largest market share for short read sequencing in the nearest future owing to its rapidly growing healthcare sector, increasing investments in genomics and a higher appreciation for personalized medicine. China and India in particular are among those countries that actively invest in the development of biotechnology and molecular biology thanks to the governments’ welcoming attitude and enough funding for the work. The continuing growth of chronic diseases and the need to identify the disease and the appropriate treatment quickly drives the adoption of short read sequencing solutions in this market.
• Moreover, increasing population in the region and increased application of new sequencing technologies in clinical and research areas are the factors which will enhance the growth of the market. That is why increasing numbers of research centers and biotechnology companies are introducing next-generation sequencing technologies into the APR because the region has all the conditions for developing genomic sequencing in the future.

Active Key Players in the Short Read Sequencing Market

• Illumina, Inc. (USA)
• Thermo Fisher Scientific, Inc. (USA)
• Pacific Biosciences of California, Inc. (USA)
• BGI (China)
• QIAGEN (Netherlands)
• Agilent Technologies (USA)
• Psomagen (USA)
• Azenta US, Inc. (GENEWIZ) (USA)
• PerkinElmer, Inc. (USA)
• ProPhase Labs, Inc. (Nebula Genomics) (USA)
• Others Key Player

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. SHORT-READ SEQUENCING MARKET BY PRODUCT (2017-2032)
   1. SHORT-READ SEQUENCING MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. INSTRUMENTS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. CONSUMABLES
   5. SERVICES
7. SHORT-READ SEQUENCING MARKET BY WORKFLOW (2017-2032)
   1. SHORT-READ SEQUENCING MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. PRE-SEQUENCING
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. SEQUENCING
   5. DATA ANALYSIS
8. SHORT-READ SEQUENCING MARKET BY APPLICATION (2017-2032)
   1. SHORT-READ SEQUENCING MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. WHOLE GENOME SEQUENCING
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. TARGETED SEQUENCING & RESEQUENCING
   5. DNA-BASED
   6. RNA-BASED
   7. OTHERS
9. SHORT-READ SEQUENCING MARKET BY END-USER (2017-2032)
   1. SHORT-READ SEQUENCING MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. ACADEMIC & RESEARCH INSTITUTES
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. HOSPITALS & CLINICS
   5. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
   6. OTHERS
10. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
       1. Competitive Positioning
       2. SHORT-READ SEQUENCING Market Share By Manufacturer (2023)
       3. Industry BCG Matrix
       4. Heat Map Analysis
       5. Mergers & Acquisitions
    2. ILLUMINA, INC. (SAN DIEGO, CALIFORNIA, USA)
       1. Company Overview
       2. Key Executives
       3. Company Snapshot
       4. Role of the Company in the Market
       5. Sustainability and Social Responsibility
       6. Operating Business Segments
       7. Product Portfolio
       8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
       9. Key Strategic Moves And Recent Developments
       10. SWOT Analysis
    3. THERMO FISHER SCIENTIFIC, INC. (WALTHAM, MASSACHUSETTS, USA)
    4. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (MENLO PARK, CALIFORNIA, USA)
    5. BGI (SHENZHEN, GUANGDONG, CHINA)
    6. QIAGEN (HILDEN, GERMANY)
    7. AGILENT TECHNOLOGIES (SANTA CLARA, CALIFORNIA, USA)
    8. PSOMAGEN (ROCKVILLE, MARYLAND, USA)
    9. AZENTA US, INC. (GENEWIZ) (SOUTH PLAINFIELD, NEW JERSEY, USA)
    10. PERKINELMER, INC. (WALTHAM, MASSACHUSETTS, USA)
    11. PROPHASE LABS, INC. (NEBULA GENOMICS) (AMBLER, PENNSYLVANIA, USA)
11. GLOBAL SHORT-READ SEQUENCING MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Product
       4. Historic And Forecasted Market Size By Workflow
       5. Historic And Forecasted Market Size By Application
       6. Historic And Forecasted Market Size By End-User
       7. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
12. INVESTMENT ANALYSIS
13. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SHORT-READ SEQUENCING MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SHORT-READ SEQUENCING MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SHORT-READ SEQUENCING MARKET COMPETITIVE RIVALRY
TABLE 005. SHORT-READ SEQUENCING MARKET THREAT OF NEW ENTRANTS
TABLE 006. SHORT-READ SEQUENCING MARKET THREAT OF SUBSTITUTES
TABLE 007. SHORT-READ SEQUENCING MARKET BY TYPE
TABLE 008. INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 009. CONSUMABLES MARKET OVERVIEW (2016-2028)
TABLE 010. SERVICES MARKET OVERVIEW (2016-2028)
TABLE 011. SHORT-READ SEQUENCING MARKET BY APPLICATION
TABLE 012. ACADEMIC RESEARCH MARKET OVERVIEW (2016-2028)
TABLE 013. CLINICAL RESEARCH MARKET OVERVIEW (2016-2028)
TABLE 014. HOSPITALS & CLINICS MARKET OVERVIEW (2016-2028)
TABLE 015. PHARMA & BIOTECH ENTITIES MARKET OVERVIEW (2016-2028)
TABLE 016. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA SHORT-READ SEQUENCING MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA SHORT-READ SEQUENCING MARKET, BY APPLICATION (2016-2028)
TABLE 019. N SHORT-READ SEQUENCING MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE SHORT-READ SEQUENCING MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE SHORT-READ SEQUENCING MARKET, BY APPLICATION (2016-2028)
TABLE 022. SHORT-READ SEQUENCING MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC SHORT-READ SEQUENCING MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC SHORT-READ SEQUENCING MARKET, BY APPLICATION (2016-2028)
TABLE 025. SHORT-READ SEQUENCING MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET, BY APPLICATION (2016-2028)
TABLE 028. SHORT-READ SEQUENCING MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA SHORT-READ SEQUENCING MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA SHORT-READ SEQUENCING MARKET, BY APPLICATION (2016-2028)
TABLE 031. SHORT-READ SEQUENCING MARKET, BY COUNTRY (2016-2028)
TABLE 032. THERMO FISHER SCIENTIFIC: SNAPSHOT
TABLE 033. THERMO FISHER SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 034. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 035. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. HOFFMANN-LA ROCHE AG: SNAPSHOT
TABLE 036. HOFFMANN-LA ROCHE AG: BUSINESS PERFORMANCE
TABLE 037. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
TABLE 038. HOFFMANN-LA ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. GE HEALTHCARE: SNAPSHOT
TABLE 039. GE HEALTHCARE: BUSINESS PERFORMANCE
TABLE 040. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 041. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. FASTERIS SA: SNAPSHOT
TABLE 042. FASTERIS SA: BUSINESS PERFORMANCE
TABLE 043. FASTERIS SA: PRODUCT PORTFOLIO
TABLE 044. FASTERIS SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. BGI GENOMICS: SNAPSHOT
TABLE 045. BGI GENOMICS: BUSINESS PERFORMANCE
TABLE 046. BGI GENOMICS: PRODUCT PORTFOLIO
TABLE 047. BGI GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. AGILENT TECHNOLOGIES: SNAPSHOT
TABLE 048. AGILENT TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 049. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 050. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. GENSCRIPT BIOTECH CORPORATION: SNAPSHOT
TABLE 051. GENSCRIPT BIOTECH CORPORATION: BUSINESS PERFORMANCE
TABLE 052. GENSCRIPT BIOTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 053. GENSCRIPT BIOTECH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. MACROGEN: SNAPSHOT
TABLE 054. MACROGEN: BUSINESS PERFORMANCE
TABLE 055. MACROGEN: PRODUCT PORTFOLIO
TABLE 056. MACROGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. GENEWIZ: SNAPSHOT
TABLE 057. GENEWIZ: BUSINESS PERFORMANCE
TABLE 058. GENEWIZ: PRODUCT PORTFOLIO
TABLE 059. GENEWIZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. QIAGEN: SNAPSHOT
TABLE 060. QIAGEN: BUSINESS PERFORMANCE
TABLE 061. QIAGEN: PRODUCT PORTFOLIO
TABLE 062. QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. ILLUMINA: SNAPSHOT
TABLE 063. ILLUMINA: BUSINESS PERFORMANCE
TABLE 064. ILLUMINA: PRODUCT PORTFOLIO
TABLE 065. ILLUMINA: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SHORT-READ SEQUENCING MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SHORT-READ SEQUENCING MARKET OVERVIEW BY TYPE
FIGURE 012. INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 013. CONSUMABLES MARKET OVERVIEW (2016-2028)
FIGURE 014. SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 015. SHORT-READ SEQUENCING MARKET OVERVIEW BY APPLICATION
FIGURE 016. ACADEMIC RESEARCH MARKET OVERVIEW (2016-2028)
FIGURE 017. CLINICAL RESEARCH MARKET OVERVIEW (2016-2028)
FIGURE 018. HOSPITALS & CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 019. PHARMA & BIOTECH ENTITIES MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA SHORT-READ SEQUENCING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE SHORT-READ SEQUENCING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC SHORT-READ SEQUENCING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA SHORT-READ SEQUENCING MARKET OVERVIEW BY COUNTRY (2016-2028)